Skip to main content
. 2022 Apr 12;16:795317. doi: 10.3389/fnins.2022.795317

TABLE 2.

Clinical severity measures in individuals with Wolfram syndrome.

TP 1 N with 1 TP TP 1a TP 2 N with 2 TPs
Disease duration (years) 4.5 ± 4.4 37 3.9 ± 4.1 5.6 ± 4.0 26
Plasma glucose (mg/dL) 187.8 ± 68.4 36 187.7 ± 72.5 181.6 ± 84.4 26
HbA1c 7.5 ± 1.5 36 7.5 ± 1.7 7.3 ± 1.1 26
WURS Physical Activity subscale score 5.0 ± 5.7 34 4.3 ± 3.2 4.5 ± 3.7 24
UPSIT total score (number correct) 24.9 ± 7.5 37 24.9 ± 7.8 24.0 ± 7.3 27
Visual acuity (logMAR) 0.56 ± 0.45 34 0.50 ± 0.34 0.56 ± 0.39* 27
Color vision (number correct) 9.2 ± 9.3 30 10.7 ± 9.4 10.2 ± 10 20
Ventral pons volume (mm3) 6280 ± 1160 27 6133 ± 1190 6030 ± 1249* 20
Brainstem volume (mm3) 15079 ± 1590 18 15079 ± 1590 14879 ± 1649** 18
Cerebellar cortex volume (mm3) 46109 ± 4440 26 45573 ± 4393 44712 ± 4420** 19
Thalamus volume (mm3) 6530 ± 478 26 6546 ± 381 6429 ± 425** 19
Follow-up duration (years, range) NA NA NA 1.8 (0.99–2.0) 27

Mean (SD) shown except where noted.

TP, time point; NA, not applicable; WURS, Wolfram United Rating Scale; UPSIT, University of Pennsylvania Smell Identification Test.

**, *p < 0.01, 0.05 relative to time point 1.

aColumn includes individuals with Wolfram syndrome who had data from both time points.